Cargando…

Natural killer cell-related gene signature predicts malignancy of glioma and the survival of patients

BACKGROUND: Natural killer (NK) cells-based therapies are one of the most promising strategies against cancer. The aim of this study is to investigate the natural killer cell related genes and its prognostic value in glioma. METHODS: The Chinese Glioma Genome Atlas (CGGA) was used to develop the nat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Chenglong, Liu, Fangkun, Sun, Lunquan, Liu, Zhixiong, Zeng, Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892793/ https://www.ncbi.nlm.nih.gov/pubmed/35236310 http://dx.doi.org/10.1186/s12885-022-09230-y

Ejemplares similares

Immune Infiltration-Related Signature Predicts Risk Stratification and Immunotherapy Efficacy in Grade II and III Gliomas
por: Luo, Cong, et al.
Publicado: (2021)

Heme Oxygenase-1 Predicts Risk Stratification and Immunotherapy Efficacy in Lower Grade Gliomas
por: Ye, Wenrui, et al.
Publicado: (2021)

PDIA3 correlates with clinical malignant features and immune signature in human gliomas
por: Zhang, Hao, et al.
Publicado: (2020)

An autophagy‐related long non‐coding RNA signature for glioma
por: Luan, Fangkun, et al.
Publicado: (2019)

Twenty Metabolic Genes Based Signature Predicts Survival of Glioma Patients
por: Xu, Wenfang, et al.
Publicado: (2020)

A novel gene signature predicts chemoradiotherapy efficacy and tumor immunity in high‐grade glioma
por: Xu, Shengchao, et al.
Publicado: (2020)

CTLA-4 correlates with immune and clinical characteristics of glioma
por: Liu, Fangkun, et al.
Publicado: (2020)

A Transcriptional Signature of PDGF-DD Activated Natural Killer Cells Predicts More Favorable Prognosis in Low-Grade Glioma
por: Sun, Yuhan, et al.
Publicado: (2021)

New Autophagy-Ferroptosis Gene Signature Predicts Survival in Glioma
por: Zhou, Liwei, et al.
Publicado: (2021)

Large-scale analysis reveals the specific clinical and immune features of CD155 in glioma
por: Liu, Fangkun, et al.
Publicado: (2019)

Identification and validation of an autophagy-related signature for predicting survival in lower-grade glioma
por: Feng, Shaobin, et al.
Publicado: (2021)

Ferroptosis-Related Gene Signature Predicts Glioma Cell Death and Glioma Patient Progression
por: Liu, Han-jie, et al.
Publicado: (2020)

A novel natural killer-related signature to effectively predict prognosis in hepatocellular carcinoma
por: Xi, Deyang, et al.
Publicado: (2023)

CD161, a promising Immune Checkpoint, correlates with Patient Prognosis: A Pan-cancer Analysis
por: Ye, Wenrui, et al.
Publicado: (2021)

The Novel-Natural-Killer-Cell-Related Gene Signature Predicts the Prognosis and Immune Status of Patients with Hepatocellular Carcinoma
por: Li, Minjun, et al.
Publicado: (2023)

Identification and validation of a 17-gene signature to improve the survival prediction of gliomas
por: Tong, Shiao, et al.
Publicado: (2022)

A novel cuproptosis-related gene signature to predict prognosis in Glioma
por: Zhang, Mengyang, et al.
Publicado: (2023)

A pseudogene-signature in glioma predicts survival
por: Gao, Kai-Ming, et al.
Publicado: (2015)

Identification of an Inflammatory Response-Related Gene Signature to Predict Survival and Immune Status in Glioma Patients
por: Yan, Zhaoyue, et al.
Publicado: (2022)

Identification of an IL-4-Related Gene Risk Signature for Malignancy, Prognosis and Immune Phenotype Prediction in Glioma
por: Qi, Ying, et al.
Publicado: (2022)

Identification of natural killer cell-related characteristics to predict the clinical prognosis and immune microenvironment of patients with low-grade glioma
por: Sun, Fei, et al.
Publicado: (2023)

Purine metabolism-related gene expression signature predicts survival outcome and indicates immune microenvironment profile of gliomas
por: Chen, Siliang, et al.
Publicado: (2022)

Identification of Immunogenic Cell Death-Related Signature for Glioma to Predict Survival and Response to Immunotherapy
por: Sun, Zhiqiang, et al.
Publicado: (2022)

Amino acid metabolism‐related gene expression‐based risk signature can better predict overall survival for glioma
por: Liu, Yu‐Qing, et al.
Publicado: (2018)

The anoikis-related gene signature predicts survival accurately in colon adenocarcinoma
por: Hu, Gunchu, et al.
Publicado: (2023)

Natural killer cell-related prognosis signature characterizes immune landscape and predicts prognosis of HNSCC
por: Chi, Hao, et al.
Publicado: (2022)

Natural killer cell-related prognosis signature predicts immune response in colon cancer patients
por: Li, Meiqin, et al.
Publicado: (2023)

Polycomb group expression signatures in the malignant progression of gliomas
por: Hu, Qi, et al.
Publicado: (2017)

The expression profiles of signature genes from CD103(+)LAG3(+) tumour-infiltrating lymphocyte subsets predict breast cancer survival
por: Xia, Zi-An, et al.
Publicado: (2023)

A Signature of Nine lncRNA Methylated Genes Predicts Survival in Patients With Glioma
por: Cheng, Meng, et al.
Publicado: (2021)

Developing an Immune-Related Signature for Predicting Survival Rate and the Response to Immune Checkpoint Inhibitors in Patients With Glioma
por: Zhang, Sibin, et al.
Publicado: (2022)

Functions of RNF Family in the Tumor Microenvironment and Drugs Prediction in Grade II/III Gliomas
por: Zhang, Jingwei, et al.
Publicado: (2022)

Uronic acid metabolic process–related gene expression–based signature predicts overall survival of glioma
por: Feng, Yuemei, et al.
Publicado: (2021)

Prediction of Survival Outcome in Lower-Grade Glioma Using a Prognostic Signature with 33 Immune-Related Gene Pairs
por: Chen, Shaohua, et al.
Publicado: (2021)

Ferroptosis‐related gene signature predicts prognosis and immunotherapy in glioma
por: Wan, Rong‐Jun, et al.
Publicado: (2021)

Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysis
por: Ye, Wenrui, et al.
Publicado: (2022)

An autophagic gene‐based signature to predict the survival of patients with low‐grade gliomas
por: Chen, Jian, et al.
Publicado: (2021)

Cellular and gene signatures of tumor-infiltrating dendritic cells and natural-killer cells predict prognosis of neuroblastoma
por: Melaiu, Ombretta, et al.
Publicado: (2020)

A new natural killer cell-specific gene signature predicting recurrence in colorectal cancer patients
por: Shembrey, Carolyn, et al.
Publicado: (2023)

Construction and Verification of a Glycolysis-Associated Gene Signature for the Prediction of Overall Survival in Low Grade Glioma
por: Liu, Wei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_inde2l6e7j6lnssakve9oaftj6